Compounded GLP-1 options allow for microdosing and personalized escalation, which can enhance safety in higher-risk populations when supervised by a qualified healthcare provider
Improved insulin sensitivity changes how your cells process glucose, and weight loss may lower your resting metabolism, meaning your body burns fewer calories at rest
Also, this medication may not be safe for people with Crohns disease , liver disease, kidney disease, heart disease, and blood dyscrasias
Current Neuropharmacology 19: 97110
Innovations are expected to focus on safety, efficacy, affordability and convenience (oral applications, auto injectors etc)